Application 021120
- Type
- NDA
- Sponsor
- SERONO INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NOVANTRONE | MITOXANTRONE HYDROCHLORIDE | INJECTABLE; INJECTION | EQ 2MG BASE/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mitoxantrone | MITOXANTRONE HYDROCHLORIDE | Fresenius Kabi USA, LLC | fcb8ef8a-f770-4416-8fc5-fa01d98c8eee | 2024-10-15 | Boxed warning, Warnings, Adverse reactions | MITOXANTRONE HYDROCHLORIDE |